Literature DB >> 15813242

Clinical findings, treatment and prognosis in patients with severe acute respiratory syndrome (SARS).

Shan-Chwen Chang.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15813242      PMCID： PMC7130064          DOI： 10.1016/S1726-4901(09)70229-1

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN： 1726-4901            Impact factor:   2.743


× No keyword cloud information.
  9 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Clinical characteristics, management and prognostic factors in patients with probable severe acute respiratory syndrome (SARS) in a SARS center in Taiwan.

Authors:  Chun-Yu Liu; Lin-Ju Huang; Chung-Hsu Lai; Hsin-Pai Chen; Te-Li Chen; Chang-Phone Fung; Cheng-Yi Liu
Journal:  J Chin Med Assoc       Date:  2005-03       Impact factor: 2.743

3.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

4.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

5.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

6.  Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.

Authors:  Wei-Kung Wang; Shey-Ying Chen; I-Jung Liu; Chuan-Liang Kao; Hui-Ling Chen; Bor-Liang Chiang; Jann-Tay Wang; Wang-Hwei Sheng; Po-Ren Hsueh; Chao-Fu Yang; Pan-Chyr Yang; Shan-Chwen Chang
Journal:  Clin Infect Dis       Date:  2004-09-01       Impact factor: 9.079

7.  Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.

Authors:  Jann-Tay Wang; Wang-Huei Sheng; Chi-Tai Fang; Yee-Chun Chen; Jiun-Ling Wang; Chong-Jen Yu; Shan-Chwen Chang; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

8.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.

Authors:  J Cinatl; B Morgenstern; G Bauer; P Chandra; H Rabenau; H W Doerr
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321
  9 in total
  6 in total

Review 1.  COVID-19: Immunology and treatment options.

Authors:  Susanna Felsenstein; Jenny A Herbert; Paul S McNamara; Christian M Hedrich
Journal:  Clin Immunol       Date:  2020-04-27       Impact factor: 3.969

2.  Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens.

Authors:  Chao-Yang Fu; He Huang; Xiao-Mei Wang; Yong-Gang Liu; Zhi-Guo Wang; Shang-Jin Cui; Hong-Lei Gao; Zan Li; Jing-Peng Li; Xian-Gang Kong
Journal:  J Virol Methods       Date:  2005-12-01       Impact factor: 2.014

Review 3.  COVID-19: what has been learned and to be learned about the novel coronavirus disease.

Authors:  Ye Yi; Philip N P Lagniton; Sen Ye; Enqin Li; Ren-He Xu
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

Review 4.  Are Mesenchymal Stem Cells able to manage Cytokine Storm in COVID-19 patients? A review of recent studies.

Authors:  Najmeh Kaffash Farkhad; Hamidreza Reihani; Alireza Sedaghat; Amir Adhami Moghadam; Ahmad Bagheri Moghadam; Jalil Tavakol-Afshari
Journal:  Regen Ther       Date:  2021-06-08       Impact factor: 3.419

Review 5.  A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.

Authors:  Anastasia Williams; Heather Branscome; Pooja Khatkar; Gifty A Mensah; Sarah Al Sharif; Daniel O Pinto; Catherine DeMarino; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2021-09-28       Impact factor: 2.643

Review 6.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.